Literature DB >> 6568875

Effects of isolated tumor lymphocytes alone and with adherent cells.

B A Blazar, N Galili, E Klein.   

Abstract

The effect on the growth of gradient-isolated mouse mammary tumor cells of different populations of lymphoid cells were evaluated in microcytotoxicity assays. Variable effects were obtained with tumor-bearer lymph node and spleen cells: in some experiments growth stimulation occurred, whereas in others inhibition was observed. Mixed effector populations gave more regular results: adherent spleen cells added to lymph node or spleen lymphocytes inhibited tumor cell growth in six of nine experiments; inhibition occurred when either of the effector populations in the mixture was derived from the tumor-bearing mouse. Tumor-associated lymphoid cells (TAL) stimulated growth of the tumor cells in five of seven experiments. However, TAL inhibited tumor growth when combined with adherent spleen cells from tumor-bearing animals. In contrast with the peripheral lymphoid cells, admixture of control adherent cells from normal animals with TAL did not inhibit growth. No natural killer effect was seen in these growth inhibition assays. These data indicate that lymphoid populations capable of inhibiting tumor cell growth can be found in tumor-bearing animals, but such combination of active cells are not present in the tumor site.

Entities:  

Mesh:

Year:  1984        PMID: 6568875     DOI: 10.1007/bf00205509

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  23 in total

1.  Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas.

Authors:  S W Russell; A T McIntosh
Journal:  Nature       Date:  1977-07-07       Impact factor: 49.962

2.  Abnormal monocyte chemotactic response in cancer patients.

Authors:  D A Boetcher; E J Leonard
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

3.  Macrophages in syngeneic animal tumours.

Authors:  R Evans
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

4.  Systemic and in situ natural killer activity in transplanted and spontaneous mammary tumors in C3H/HeN mice.

Authors:  J M Gerson; A Tagliabue; R B Herberman
Journal:  J Reticuloendothel Soc       Date:  1981-01

Review 5.  An immunostimulation theory of tumor development.

Authors:  R T Prehn; M A Lappé
Journal:  Transplant Rev       Date:  1971

6.  In situ lymphoid cells of mouse mammary tumors. I. Development and evaluation of a method for the separation of lymphoid cells from mouse mammary tumors.

Authors:  B A Blazar; G H Heppner
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  Suppression of antibody-sensitized tumor cells by macrophages: insufficient supply or activation of macrophages within large tumors.

Authors:  R J Johnson; R F Siliciano; H S Shin
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

8.  Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action.

Authors:  R Evans
Journal:  Int J Cancer       Date:  1984-03-15       Impact factor: 7.396

9.  Antiinflammatory effects of murine malignant cells.

Authors:  R M Fauve; B Hevin; H Jacob; J A Gaillard; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

10.  Systemic and in situ natural killer and suppressor cell activities in mice bearing progressively growing murine sarcoma-virus-induced tumors.

Authors:  J Gerson; L Varesio; R B Herberman
Journal:  Int J Cancer       Date:  1981-02-15       Impact factor: 7.396

View more
  3 in total

1.  Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection.

Authors:  H F Dullens; R A De Weger; M Van der Maas; P J Den Besten; R J Vandebriel; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Purified mouse mammary tumor and lymphoid cells in immune assays.

Authors:  B A Blazar; F Vanky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice.

Authors:  R A De Weger; B Wilbrink; R M Moberts; D Mans; R Oskam; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.